Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Payments to Acquire Businesses and Interest in Affiliates

EMERGENT BIOSOLUTIONS INC. Payments to Acquire Businesses and Interest in Affiliates

EMERGENT BIOSOLUTIONS INC. (EBS) reported Payments to Acquire Businesses and Interest in Affiliates of $0 for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates · last filed 2014-11-10

  • 2014-09-30: Payments to Acquire Businesses and Interest in Affiliates 9 month $0.00.
  • 2013-09-30: Payments to Acquire Businesses and Interest in Affiliates 9 month $24.12M.
Period endPayments to Acquire Businesses and Interest in Affiliates 9 month
2014-09-30$0.00
10-Q · filed 2014-11-10
2013-09-30$24.12M
10-Q · filed 2014-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45